Related Experiment Videos
Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging
Peter L Choyke1, Andrew J Dwyer, Michael V Knopp
1Department of Radiology, National Institutes of Health, Bethesda, Maryland 20892-1162, USA. pchoyke@nih.gov
Journal of Magnetic Resonance Imaging : JMRI
|April 30, 2003
Summary
Dynamic contrast-enhanced MRI (DCE-MRI) provides detailed tumor kinetics, aiding in characterization and therapy monitoring. Research aims to enhance its molecular understanding and clinical utility.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Dynamic contrast-enhanced MRI (DCE-MRI) captures serial images during contrast agent administration.
- It offers insights into tumor vascularity and tissue properties beyond conventional MRI.
- DCE-MRI visualizes contrast agent wash-in and wash-out kinetics within tumors.
Purpose of the Study:
- To detail the principles and applications of DCE-MRI in tumor assessment.
- To explore the use of pharmacokinetic modeling for DCE-MRI data analysis.
- To discuss current limitations and future research directions in DCE-MRI.
Main Methods:
- Acquisition of serial MRI scans before, during, and after contrast agent injection.
- Application of two-compartment pharmacokinetic modeling to DCE-MRI data.
- Generation of color-encoded parametric maps for tumor visualization.
Main Results:
- DCE-MRI provides functional information on tumor bulk tissue properties.
- Pharmacokinetic parameters derived from DCE-MRI aid in tumor characterization and staging.
- Color-encoded images enhance visual assessment of tumor characteristics.
Conclusions:
- DCE-MRI is valuable for tumor characterization, staging, and therapy monitoring.
- Limitations include overlap with benign tissues and inconsistent predictive value.
- Future research focuses on molecular insights, novel agents, and multimodal imaging integration.